首页> 美国卫生研究院文献>The International Journal of Angiology : Official Publication of the International College of Angiology Inc >Effectiveness of Tunneled Pleural Catheter Placement in Patients with Malignant Pleural Effusions
【2h】

Effectiveness of Tunneled Pleural Catheter Placement in Patients with Malignant Pleural Effusions

机译:恶性胸腔积液患者行穿刺胸膜导管置入术的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pleural effusions (PE) occur frequently among patients with various types of advanced malignancies, resulting in remarkably decreased quality of life. Treatment of malignant PE includes placement of a chest tube with subsequent placement of a tunneled pleural catheter. We reviewed our experience with tunneled pleural catheter use to assess outcomes and resource utilization of this intervention. A retrospective study of consecutive patients (n = 163, including 41 outpatients) who were treated between July 2001 and April 2008 with tunneled pleural catheters was performed to evaluate operative and discharge outcomes. The average age of the patients was 59.32 years (range: 24 to 89). Lung cancer, breast cancer, and ovarian cancer were common primary diseases in this patient population. The mean hospital stay after tunneled pleural catheter placement was 3.19 days (range: 0 to 56), with 41 patients treated as outpatients. Thirteen inpatient deaths were related to the patients' primary diseases, but no deaths were due to drain placement itself. Eight patients (4.91%) required reoperation to replace a nonfunctioning drain or to add an additional drain, and six patients underwent a second procedure to place a contralateral drain. One hundred twenty-six patients (77.30%) were discharged home following the procedure and hospital stay. Fifty-five people achieved spontaneous pleurodesis. Tunneled pleural catheter placement is a safe and effective approach to the treatment of PE. The advantages of tunneled pleural catheter placement include symptomatic relief and improved quality of life. This method allows patients to spend time at home with their family and avoid prolonged hospitalization.
机译:胸腔积液(PE)在各种类型的晚期恶性肿瘤患者中频繁发生,导致生活质量明显下降。恶性PE的治疗包括放置胸管,随后放置隧道胸膜导管。我们回顾了我们使用隧道胸膜导管的经验,以评估该干预措施的结果和资源利用情况。回顾性分析2001年7月至2008年4月间使用隧道胸膜导管治疗的连续患者(n = 163,包括41名门诊患者),以评估手术和出院结果。患者的平均年龄为59.32岁(范围:24至89)。在该患者人群中,肺癌,乳腺癌和卵巢癌是常见的原发疾病。放置胸膜导管后平均住院时间为3.19天(范围:0至56天),其中41例患者为门诊患者。十三例住院死亡与患者的原发疾病有关,但没有死亡是由于引流管本身造成的。八名患者(4.91%)需要再次手术以更换无功能的引流管或增加额外的引流管,六名患者接受了第二次手术以放置对侧引流管。手术和住院后,有126例患者(77.30%)出院。五十五个人实现了自发性胸膜固定术。隧道式胸膜导管置入术是治疗PE的安全有效方法。隧道式胸膜导管置入术的优点包括症状缓解和生活质量改善。这种方法使患者可以与家人一起度过时间,避免长时间住院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号